THC Therapeutics, Inc. (THCT)

THC Therapeutics Income Statement

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Selling, General & Admin	0.54	0.49	1.75	0.94	1.39
Operating Expenses	0.54	0.49	1.75	0.94	1.39
Operating Income	-0.54	-0.49	-1.75	-0.94	-1.39
Interest Expense	-0.14	-0.08	-0.1	-0.55	-0.49
Other Non Operating Income (Expenses)	-0.13	0.18	0.33	-0.39	0.12
EBT Excluding Unusual Items	-0.81	-0.39	-1.52	-1.89	-1.75
Gain (Loss) on Sale of Investments	-	-	-	-	-0.01
Other Unusual Items	-	0	-	-	-0.17
Pretax Income	-0.81	-0.39	-1.52	-1.89	-1.93
Net Income	-0.81	-0.39	-1.52	-1.89	-1.93
Net Income to Common	-0.81	-0.39	-1.52	-1.89	-1.93
Shares Outstanding (Basic)	36	33	33	24	17
Shares Outstanding (Diluted)	36	33	33	24	17
Shares Change (YoY)	8.76%	-1.32%	40.51%	42.95%	23.73%
EPS (Basic)	-0.02	-0.01	-0.05	-0.08	-0.12
EPS (Diluted)	-0.02	-0.01	-0.05	-0.08	-0.12
Free Cash Flow	-0.18	-0.09	-0.42	-0.39	-0.59
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.02	-0.04
EBITDA	-0.54	-0.49	-1.73	-0.92	-1.37
D&A For EBITDA	0	0	0.01	0.02	0.02
EBIT	-0.54	-0.49	-1.75	-0.94	-1.39
Advertising Expenses	-	-	-	0.03	0.05

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error